Clinical Trials
34 trialsN01-A-PICIT-GT
Peking University People's Hospital
Diet, Hepcidin, and Chemotherapy RDI
George Washington University
NIRAPK
Hospices Civils de Lyon
Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer
AstraZeneca
Newton
Mario Negri Institute for Pharmacological Research
GynCAT
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)
AstraZeneca
C-PATROL
AstraZeneca
Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients
University of Wisconsin, Madison
Mini-allo
Scripps Health
Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy
Duke University
LUSTIC
Medical University of Vienna
SPACE2
Weprom
Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.
Sunnybrook Health Sciences Centre
GALENO 1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Methods in Education for Breast Cancer Genetics
National Institutes of Health Clinical Center (CC)
ICEBERG 3
AstraZeneca
PSICOM
University Hospital, Montpellier
REVIVAL
The Netherlands Cancer Institute
Venous Thromboembolic Complications in Ovarian Cancer
Aalborg University Hospital
ICEBERG 2
AstraZeneca
Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer
Tarix Pharmaceuticals
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Amgen
Genetic Counseling in African American Women
University of Pennsylvania
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Altor BioScience
REACH
University of Utah
Monitor-GCSF
Sandoz
Lynne Cohen Consortium Project: Multi-Center Database/Registry
M.D. Anderson Cancer Center
MITO15
Catholic University of the Sacred Heart
Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing
Dana-Farber Cancer Institute
The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy
Amgen
Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer
National Taiwan University Hospital